The FDA is seeking subject matter experts to join its new Digital Health Advisory Committee. The role of the committee will be to support safe and effective regulation of digital health technologies while encouraging innovation, and to solicit views from technical and scientific subject matter experts from diverse disciplines and backgrounds.

The Digital Health Advisory Committee will advise the Commissioner of Food and Drugs on issues related to Digital Health Technologies (DHTs), and FDA policies and regulations about these technologies, providing relevant expertise and perspective to improve the FDA’s understanding of the benefits, risks and clinical outcomes associated with use of DHTs, as well as identifying risks, barriers or unintended consequences that could result from proposed or established FDA policy or regulation for topics related to DHTs. This also may include advice on the use of DHTs in clinical trials or post-market studies subject to the FDA’s regulation.

The Committee will consist of a core of nine voting members including the Chair. Members and the Chair are selected by the FDA Commissioner or designee from among authorities knowledgeable in the fields of digital health. The number of temporary members selected for a particular meeting will depend on the meeting topic.

How to Apply

In its call for members, the FDA noted that it is looking to solicit views from technical and scientific subject matter experts from diverse disciplines and backgrounds, including both women and men, members of all racial and ethnic groups, and individuals with and without disabilities, for this advisory committee and, therefore encourages nominations of appropriately qualified candidates from these groups.

If you would like to serve or nominate a representative to serve as a voting or non-voting member of the  Digital Health Advisory Committee, you can submit your nomination electronically by accessing the FDA Advisory Committee Membership Nomination Portal or by mail to:

Advisory Committee Oversight and Management Staff
Food and Drug Administration
10903 New Hampshire Ave.
Bldg. 32, Rm. 5103
Silver Spring. 20993-0002.

Nominations should be submitted no later than December 11, 2023. Applications should include a current, complete résumé or curriculum vitae for each nominee, including a current business and home address, telephone number and email address if available.